Latest Insider Transactions at Kiniksa Pharmaceuticals, Ltd. (KNSA)
This section provides a real-time view of insider transactions for Kiniksa Pharmaceuticals, Ltd. (KNSA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Kiniksa Pharmaceuticals, Ltd. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Kiniksa Pharmaceuticals, Ltd.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 05
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,272
-39.98%
|
$175,616
$28.0 P/Share
|
|
May 05
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,272
+28.56%
|
$106,624
$17.76 P/Share
|
|
May 02
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,850
-29.02%
|
$107,800
$28.0 P/Share
|
|
May 02
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,850
+22.49%
|
$65,450
$17.76 P/Share
|
|
May 01
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
23,234
-71.16%
|
$650,552
$28.02 P/Share
|
|
May 01
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
23,234
+20.67%
|
$325,276
$14.07 P/Share
|
|
May 01
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
25,141
-48.21%
|
$678,807
$27.8 P/Share
|
|
May 01
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,141
+21.83%
|
$427,397
$17.84 P/Share
|
|
Apr 30
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
21,254
-44.04%
|
$552,604
$26.95 P/Share
|
|
Apr 30
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
21,254
+30.57%
|
$340,064
$16.9 P/Share
|
|
Apr 29
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
64,035
-87.18%
|
$1,600,875
$25.21 P/Share
|
|
Apr 29
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
64,035
+21.75%
|
$832,455
$13.34 P/Share
|
|
Apr 29
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
42,000
-60.86%
|
$1,050,000
$25.61 P/Share
|
|
Apr 29
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
42,000
+27.01%
|
$630,000
$15.51 P/Share
|
|
Apr 26
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
479
-1.74%
|
$10,059
$21.36 P/Share
|
|
Apr 26
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
990
+3.48%
|
-
|
|
Apr 21
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
18,259
-65.98%
|
$365,180
$20.29 P/Share
|
|
Apr 14
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
12,000
-6.95%
|
$240,000
$20.47 P/Share
|
|
Apr 14
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+7.26%
|
$21,000
$3.8 P/Share
|
|
Apr 07
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,303
-4.69%
|
$26,060
$20.28 P/Share
|
|
Apr 07
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,694
+8.83%
|
-
|
|
Apr 07
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
801
-0.96%
|
$16,020
$20.28 P/Share
|
|
Apr 07
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,726
+3.17%
|
-
|
|
Apr 07
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,666
-4.87%
|
$33,320
$20.28 P/Share
|
|
Apr 07
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,933
+10.31%
|
-
|
|
Apr 07
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
727
-2.56%
|
$14,540
$20.28 P/Share
|
|
Apr 07
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,477
+8.02%
|
-
|
|
Apr 07
2025
|
John F. Paolini CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
734
-1.26%
|
$14,680
$20.28 P/Share
|
|
Apr 07
2025
|
John F. Paolini CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,498
+4.12%
|
-
|
|
Apr 07
2025
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,832
-4.76%
|
$96,640
$20.28 P/Share
|
|
Apr 07
2025
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,992
+8.96%
|
-
|
|
Apr 01
2025
|
John F. Paolini CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
991
-0.88%
|
$20,811
$21.77 P/Share
|
|
Apr 01
2025
|
John F. Paolini CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,374
+2.94%
|
-
|
|
Apr 01
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
984
-1.85%
|
$20,664
$21.77 P/Share
|
|
Apr 01
2025
|
Ross Moat CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,352
+6.05%
|
-
|
|
Apr 01
2025
|
Sanj K Patel CHAIRMAN & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,321
-2.79%
|
$111,741
$21.77 P/Share
|
|
Apr 01
2025
|
Sanj K Patel CHAIRMAN & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,719
+6.36%
|
-
|
|
Apr 01
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,034
-0.64%
|
$21,714
$21.77 P/Share
|
|
Apr 01
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,519
+2.14%
|
-
|
|
Apr 01
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,617
-3.07%
|
$33,957
$21.77 P/Share
|
|
Apr 01
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,342
+6.07%
|
-
|
|
Apr 01
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,084
-3.27%
|
$43,764
$21.77 P/Share
|
|
Apr 01
2025
|
Michael R Megna CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,920
+7.33%
|
-
|
|
Mar 20
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
15,944
-40.54%
|
$366,712
$23.11 P/Share
|
|
Mar 20
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,944
+28.85%
|
$191,328
$12.97 P/Share
|
|
Mar 19
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
8,879
-27.52%
|
$204,217
$23.1 P/Share
|
|
Mar 19
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,879
+21.58%
|
$106,548
$12.97 P/Share
|
|
Mar 17
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
11,464
-32.9%
|
$263,672
$23.1 P/Share
|
|
Mar 17
2025
|
Mark Ragosa CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,464
+24.75%
|
$137,568
$12.97 P/Share
|
|
Mar 16
2025
|
Eben Tessari CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
577
-0.73%
|
$12,694
$22.61 P/Share
|